Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 9, Pages e24012
Publisher
Public Library of Science (PLoS)
Online
2011-09-08
DOI
10.1371/journal.pone.0024012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
- (2015) Oncotarget
- Mcl-1 Ubiquitination and Destruction
- (2015) Hiroyuki Inuzuka et al. Oncotarget
- Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF)
- (2010) Erik Norberg et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
- (2010) D. Yecies et al. BLOOD
- Actinomycin D Decreases Mcl-1 Expression and Acts Synergistically with ABT-737 against Small Cell Lung Cancer Cell Lines
- (2010) H. Xu et al. CLINICAL CANCER RESEARCH
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+Signaling
- (2010) Emily F. Eckenrode et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Melanoma Activity of the 9.2.27PE Immunotoxin in Dacarbazine Resistant Cells
- (2010) Karianne Risberg et al. JOURNAL OF IMMUNOTHERAPY
- ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
- (2010) R. Traini et al. MOLECULAR CANCER THERAPEUTICS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bcl-2 family on guard at the ER
- (2009) Eva Szegezdi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Integrating BRAF/MEK inhibitors into combination therapy for melanoma
- (2009) K S M Smalley et al. BRITISH JOURNAL OF CANCER
- Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
- (2009) Y Andersson et al. BRITISH JOURNAL OF CANCER
- The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cellsin vitro
- (2009) Karianne Risberg et al. INTERNATIONAL JOURNAL OF CANCER
- Dual Mechanisms of sHA 14-1 in Inducing Cell Death through Endoplasmic Reticulum and Mitochondria
- (2009) D. Hermanson et al. MOLECULAR PHARMACOLOGY
- Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor
- (2008) Yi-Ping Rong et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
- (2008) K. D. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search